Glen Hazlewood, McGill University

Research

Drug Effectiveness Drug Safety Health Outcomes Research Patient Preferences Rheumatology Systemic Lupus Comparative Effectiveness And Safety Confounding Bias

Latest papers

Position Statement: A Pragmatic Approach for Medical Cannabis and Patients with Rheumatic Diseases.
The Journal of rheumatology · 2019 · senior author
Determining Best Practices in Early Rheumatoid Arthritis by Comparing Differences in Treatment at Sites in the Canadian Early Arthritis Cohort
The Journal of Rheumatology · 2013

All 2 publications

Latest funding

Personalizing Therapy to Optimize Outcomes by Synthesizing Real-World Evidence and Establishing Patient Preferences
CIHR · 2026 · Principal investigator
$443,700
Enhancing CAN-AIM capacity to respond to drug safety and effectiveness queries
CIHR · 2019 · Principal investigator
$2,550,000
Comparative Effectiveness and Safety of Biosimilar and Legacy Drugs
CIHR · 2017 · Co-investigator
$1,769,650

All 4 grants and awards

2 publications.

01

Position Statement: A Pragmatic Approach for Medical Cannabis and Patients with Rheumatic Diseases.

Fitzcharles MA, Niaki OZ, Hauser W, Hazlewood G, Canadian Rheumatology Association

The Journal of rheumatology2019Senior author

DOI: 10.3899/jrheum.181120 PMID: 30647183

02

Determining Best Practices in Early Rheumatoid Arthritis by Comparing Differences in Treatment at Sites in the Canadian Early Arthritis Cohort

The Journal of Rheumatology201327 citationsOpen Access

DOI: 10.3899/jrheum.121316 PMID: W2055738362

Personalizing Therapy to Optimize Outcomes by Synthesizing Real-World Evidence and Establishing Patient Preferences

Principal investigatorCIHR2026Project Grant

Principal investigators: Bernatsky, Sasha R; Hazlewood, Glen S

Keywords: Drug Effectiveness; Drug Safety; Health Outcomes Research; Patient Preferences; Rheumatology; Systemic Lupus

$443,700

Enhancing CAN-AIM capacity to respond to drug safety and effectiveness queries

Principal investigatorCIHR2019DSEN team grants: MAGIC and CAN-AIM

Principal investigators: Bernatsky, Sasha R; Abrahamowicz, Michal M; Afif, Waqqas; Awadalla, Philip; Bérard, Anick; Buckeridge, David L; Hazlewood, Glen S; Hohl, Corinne M; Kowalec, Kaarina A; Moride, Yola; Moura, Cristiano S; Pilote, Louise; Tremlett, Helen L

Keywords: Comparative Effectiveness And Safety; Confounding Bias; Exposure Measurement Errors; Pharmacoepidemiology; Prospective Studies; Statistical Modelling

$2,550,000

Comparative Effectiveness and Safety of Biosimilar and Legacy Drugs

Co-investigatorCIHR2017Rapid Funding for DSEN Targeted Research

Principal investigators: Bernatsky, Sasha R; Boire, Gilles; Bykerk, Vivian P; Lakatos, Peter; Maksymowych, Walter P; Moura, Cristiano S; Targownik, Laura E

Keywords: Des

$1,769,650

Hydroxychloroquine in systemic lupus

Principal investigatorCIHR2017Project Grant

Principal investigators: Bernatsky, Sasha R; Hazlewood, Glen S

Keywords: Drug Effectiveness; Drug Safety; Epidemiology; Rheumatic Diseases; Systemic Lupus Erythematosis

$342,340

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Frequent collaborators

Medicine
Other

Co-authors at McGill University, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.

Gilles Boire

Faculty

1 shared papers, latest 2013

Glen Hazlewood

Medicine

1 shared papers, latest 2019

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2026

Subject: Prospective PhD student: Drug Effectiveness Dear Professor Hazlewood, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Position Statement: A Pragmatic Approach for Medical Cannabis and Patients with Rheumatic Diseases." (2019), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Personalizing Therapy to Optimize Outcomes by Synthesizing Real-World Evidence and Establishing Patient Preferences" (2026), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]